Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Search Site

Over 2,750 Pages of
Hepatitis C Info, Here:
Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases SAN DIEGO

Domingo Hit With Hepatitis B, Rocha Fight Called Off
By Ronnie Nathanielsz WBO Oriental bantamweight champion Michael Domingo's scheduled fight against Nestor Rocha at the Morongo Casino & Spa in Cabazon, California on November 22 (Manila Time) has been called off. Domingo who trained at the Mayweather Gym

HIV negative at 3 months. What about Hepatitis C coinfection?
I am a heterosexual male who was drugged and raped. The place where I believe the incident occurred is a motel where a lot of drug users/truckers go. I have a 3 month negative HIV antibody test. I was told to come back for a 6 month (agghhhhhhh!!!...ok,

UPDATES AND COMMENTARY RSS Feed

Who Will Respond to Hepatitis C Treatment
The relatively new field of proteomics may be able to predict who will respond to Hepatitis C therapy - before treatment even begins....

Antivirals Combined Without Interferon: New Trial
Three companies unite to begin an innovative Hepatitis C trial, where two oral antiviral drugs will be combined in the absence of interferon....

HCV May Be Able to Be Cleared from Both Blood and Liver
Viral clearance doubled in a Hepatitis C Phase II trial during standard therapy when coupled with GlobeImmune's GI-5005. Because Hepatitis C must be eradicated not just from the blood, but also the liver, GI-5005's ability to speed the clearance rate...

Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity

Figure 1:   Results of the Italian6 and French7 studies are compared. The prevalences of cirrhosis in essential mixed cryoglobulinaemia (EMC) and in cryoglobulinaemia secondary to chronic liver disease (2° CLD) are shown. The prevalences of the type of cryoglobulinaemia (II or III) and rheumatoid factor (RF) and antibodies to hepatitis C virus antigens (HCV Ab) in the serum are shown for each group. Reprinted from Agnello V,8 with permission of the publisher.

Return To Article

© 1998 by Annals of the Rheumatic Diseases
  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 21 Nov 2008